{{chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 462260686
| ImageFile_Ref = {{chemboximage|correct|??}}
| ImageFile=File:Niguldipine structure.svg
| ImageSize=
| IUPACName=3-3-(4,4-Diphenyl-1-piperidyl)propyl 5-methyl 2,6-dimethyl-4-(''m''-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
| OtherNames=
|Section1={{Chembox Identifiers
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = Z81N45O25Z
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 1199
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 41929
| InChI = 1/C36H39N3O6/c1-25-31(34(40)44-3)33(27-12-10-17-30(24-27)39(42)43)32(26(2)37-25)35(41)45-23-11-20-38-21-18-36(19-22-38,28-13-6-4-7-14-28)29-15-8-5-9-16-29/h4-10,12-17,24,33,37H,11,18-23H2,1-3H3
| InChIKey = SVJMLYUFVDMUHP-UHFFFAOYAB
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C36H39N3O6/c1-25-31(34(40)44-3)33(27-12-10-17-30(24-27)39(42)43)32(26(2)37-25)35(41)45-23-11-20-38-21-18-36(19-22-38,28-13-6-4-7-14-28)29-15-8-5-9-16-29/h4-10,12-17,24,33,37H,11,18-23H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = SVJMLYUFVDMUHP-UHFFFAOYSA-N
| CASNo_Ref = {{cascite|changed|CAS}}
| CASNo = 113165-32-5
| PubChem= 1236	
| SMILES = [O-][N+](=O)c1cccc(c1)C5C(/C(=O)OC)=C(\N\C(=C5\C(=O)OCCCN4CCC(c2ccccc2)(c3ccccc3)CC4)C)C
}}
|Section2={{Chembox Properties
| Formula=C<sub>36</sub>H<sub>39</sub>N<sub>3</sub>O<sub>6</sub>
| MolarMass=609.71136
| Appearance=
| Density=
| MeltingPt=
| BoilingPt=
| Solubility=
  }}
|Section3={{Chembox Hazards
| MainHazards=
| FlashPt=
| AutoignitionPt =
  }}
}}

'''Niguldipine''' is a [[calcium channel blocker]] and [[alpha-1 adrenergic receptor|a<sub>1</sub>-adrenergic receptor]] [[receptor antagonist|antagonist]].<ref name="pmid2548881">{{cite journal |vauthors=Boer R, Grassegger A, Schudt C, Glossmann H | title = (+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptors | journal = European Journal of Pharmacology | volume = 172 | issue = 2 | pages = 131â€“45 |date=May 1989 | pmid = 2548881 | doi = 10.1016/0922-4106(89)90004-7| url = }}</ref>

== References ==
{{Reflist}}

{{Antihypertensives}}
{{Calcium channel blockers}}
{{Adrenergics}}

[[Category:Calcium channel blockers]]
[[Category:Dihydropyridines]]
[[Category:Carboxylate esters]]
[[Category:Nitrobenzenes]]
[[Category:Piperidines]]


{{Cardiovascular-drug-stub}}